These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33896688)

  • 1. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses.
    Siggins MK; Thwaites RS; Openshaw PJM
    Trends Microbiol; 2021 Jul; 29(7):648-662. PubMed ID: 33896688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    Simmonds P; Williams S; Harvala H
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33331810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
    Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
    Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to SARS-CoV-2: Lessons Learned.
    Fergie J; Srivastava A
    Front Immunol; 2021; 12():654165. PubMed ID: 33815415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects.
    Zheng J; Deng Y; Zhao Z; Mao B; Lu M; Lin Y; Huang A
    Cell Mol Immunol; 2022 Feb; 19(2):150-157. PubMed ID: 34645940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
    Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
    Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z;
    Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea.
    Yum S; Hong K; Sohn S; Kim J; Chun BC
    Emerg Infect Dis; 2021; 27(6):1685-1688. PubMed ID: 34013875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
    Fröberg J; Diavatopoulos DA
    Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characteristics govern the transition of COVID-19 to endemicity.
    Lavine JS; Bjornstad ON; Antia R
    Science; 2021 Feb; 371(6530):741-745. PubMed ID: 33436525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines.
    Murano K; Guo Y; Siomi H
    Biochem Soc Trans; 2021 Dec; 49(6):2879-2890. PubMed ID: 34854887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive immune responses to SARS-CoV-2.
    Forthal D
    Adv Drug Deliv Rev; 2021 May; 172():1-8. PubMed ID: 33610693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
    Gusev E; Sarapultsev A; Solomatina L; Chereshnev V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
    Borrega R; Nelson DKS; Koval AP; Bond NG; Heinrich ML; Rowland MM; Lathigra R; Bush DJ; Aimukanova I; Phinney WN; Koval SA; Hoffmann AR; Smither AR; Bell-Kareem AR; Melnik LI; Genemaras KJ; Chao K; Snarski P; Melton AB; Harrell JE; Smira AA; Elliott DH; Rouelle JA; Sabino-Santos G; Drouin AC; Momoh M; Sandi JD; Goba A; Samuels RJ; Kanneh L; Gbakie M; Branco ZL; Shaffer JG; Schieffelin JS; Robinson JE; Fusco DN; Sabeti PC; Andersen KG; Grant DS; Boisen ML; Branco LM; Garry RF
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.